[Serum neopterin in Behçet's disease]

Area of Science:

• Immunology
• Rheumatology
• Biochemistry

Background:

• Behcet's disease (BD) is a multisystem inflammatory disorder of unknown etiology.
• Cellular immune activation is implicated in the pathogenesis of BD.
• Neopterin is a biomarker of cellular immune activation.

Purpose of the Study:

• To investigate serum neopterin concentrations in patients with Behcet's disease.
• To explore the correlation between neopterin levels, clinical manifestations (pathergy test), and inflammatory markers (CRP).

Main Methods:

• Radioimmunoassay was used to measure serum neopterin levels.
• 26 male and 12 female BD patients and healthy controls were included.
• Statistical analysis was performed to compare groups and assess correlations.

Main Results:

• Mean serum neopterin concentrations were significantly higher in BD patients compared to controls (8.7 +/- 4.1 nmol/l vs. 5.0 +/- 1.9 nmol/l).
• Neopterin levels were significantly higher in BD patients with a positive pathergy test.
• A significant positive correlation was observed between serum neopterin and C-reactive protein (CRP) levels (rs=0.42, p<0.02).

Conclusions:

• Elevated serum neopterin levels suggest activated cellular immunity in Behcet's disease.
• Neopterin may serve as a useful biomarker for immune activation in BD.
• Further research is warranted to elucidate the role of neopterin in BD pathogenesis.